The New Criterion’s Tim Boreham shines the light on family-run dental products manufacturer SDI (Formerly Southern Dental Industries)
Gentrack is emerging as a potential key player in the cloud native, SaaS based utility meters sector, where utilities are under invested and thus requiring a major upgrade cycle, in the transition to sustainability and net zero emissions
Jumbo Interactive has been benefiting from a run of big lottery jackpots, but is this a trend or a blip? Citi has concerns, initiating coverage with a Sell rating
In the wake of Telix Pharmaceuticals’ non-IPO on the Nasdaq, FNArena shines a light on the company’s fortunes and that of Australian biotech and cancer research generally
Analysts highlight structural tailwinds for Ventia Services and margin protection from contract mix and flexible costs
Following its near-death experience last year, BNPL provider Zip Co has made a strong comeback. Evans & Partners has initiated coverage
Superloop management has raised FY24 earnings guidance and confirmed the Origin Energy customer transition is on track. Analysts see additional growth opportunities
The New Criterion’s Tim Boreham explains the how and why behind Radiopharm Theranostics’ latest capital raising
Brokers highlight deregulation and scale benefits from the potential merger of Integral Diagnostics and Capitol Health
Deterra Royalties is looking to diversify away from iron ore royalties and provide for growth, in lithium in particular. The trade-off is a much-reduced dividend yield